Skip to content

Design Control Traceability Matrix

Design Control That Survives Change

qmsWrapper provides a Design Control Traceability Matrix built to support structured documentation across the FDA Design History File (DHF) and EU MDR Technical File.

It connects user needs, requirements, risks, design inputs and outputs, verification, and validation into one maintained structure.

Linked records and controlled updates help preserve consistency as your design evolves.

When design changes occur, linked elements can be reviewed within the same structured environment.

Design Control Software for Medical Devices: Laptop screen displaying the qmsWrapper Traceability Matrix with linked use cases, requirements, risk levels, risk mitigation, and test records in a live, connected DHF view.

Traceability Is Not a Table. It’s a System.

In many systems, the Traceability Matrix is treated as a generated report — reviewed primarily before audits.

In qmsWrapper, the Design Traceability File (DTF) is built on structured forms and linked records.

Each requirement, risk, test, and design output exists as an individual, revision-controlled record — connected through structured references.

The problem: Traceability Breaks When Things Change

When traceability depends on manual linking, spreadsheets, or exported reports, design control becomes difficult to maintain consistently.

Design control is tested when requirements evolve, risks are reassessed, or verification results require updates.

If links are maintained outside the system, consistency depends on manual effort rather than structure.

Split-screen illustration comparing static and live traceability in a medical device QMS, showing broken links between requirement, risk, and test on the left and fully connected, automatically updated traceability on the right.

When Events Affect Design, Traceability Must Be Reviewed

Design changes rarely happen in isolation.

They may be triggered by Events like deviations, nonconformity, change or feedback.

In qmsWrapper, design-related records remain accessible within the same structured environment as quality records.

When a design element is updated, linked requirements, risks, and tests can be reviewed to ensure consistency.

The system supports structured review — helping teams maintain alignment across related records.

Diagram showing how a quality event connects to use case, requirement, risk, design input/output, and test within a live medical device traceability system.
AI-assisted record review illustration showing a central requirement (R-12) connected to linked risk, design output, and test protocol records on a red background.
Minimalist vector illustration of a Design History File document stack with a professional VERIFIED approval stamp, flanked by subtle EU and FDA compliance shield symbols, representing audit and submission readiness.

Built for Regulatory Review

The Traceability Matrix supports:

  • DHF and Technical File structure
  • 510(k) submissions
  • CE Marking under MDR

Auditors and Notified Bodies can review the traceability chain from requirement to evidence within a structured environment.

Clear record linkage reduces the need for manual reconstruction before audits.

More Than a Matrix — A Structured Design Traceability File

The Design Traceability File (DTF) supports both the FDA Design History File (DHF) and the EU MDR Technical File within one structured documentation environment.

It preserves the logical relationship between requirements, risks, and evidence — ensuring consistency as your design evolves.

Regulators do not review isolated documents.
They review traceable design reasoning.

The DTF maintains that continuity.

“Traceability is evidence of design logic”

If you are preparing for MDR, FDA 21 CFR 820, or ISO 13485 audits, a structured and consistently maintained traceability system can reduce reconstruction effort and audit risk.

Book a meeting to see how the Design Control Traceability Matrix supports your regulatory documentation process.


Frequently Asked Questions About Design Control and Traceability in Medical Devices

What is a Design Control Traceability Matrix in medical devices?

A Design Control Traceability Matrix in medical devices links user needs, design requirements, risks, design inputs and outputs, and verification and validation evidence within a structured documentation system. It ensures that every requirement is traceable to risk analysis and test results in accordance with FDA 21 CFR 820 and ISO 13485.

Is a Traceability Matrix required for FDA and MDR compliance?

While regulations do not mandate a specific “matrix” format, both FDA 21 CFR 820 and EU MDR require documented design control and traceability. A structured traceability matrix helps demonstrate that requirements, risks, and verification activities are consistently linked within the Design History File (DHF) and Technical File.

How does traceability support ISO 13485 design control?

ISO 13485 requires documented design inputs, outputs, review, verification, validation, and risk management. A Design Control Traceability Matrix supports compliance by maintaining structured relationships between these elements throughout the product lifecycle.

What is the difference between a Design History File and a Technical File?

The Design History File (DHF) is an FDA requirement documenting design control activities under 21 CFR 820. The Technical File under EU MDR contains similar evidence but follows European regulatory structure. A structured traceability system helps maintain consistency between both documentation sets.

How does traceability reduce audit risk?

Traceability reduces audit risk by ensuring that requirements, risks, and test evidence are linked within a controlled system. This minimizes manual reconstruction before inspections and allows auditors to follow the chain of design reasoning without relying on disconnected documents.

Can AI be used in design control documentation?

AI can assist with reviewing linked records, identifying related risks or test protocols, and retrieving documentation across modules. However, regulatory responsibility remains with the manufacturer, and final design decisions must remain under human control.